日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy

抑制 ADAM9 可促进 KRAS 的选择性降解,使胰腺癌对化疗敏感

Yu-Kai Huang, Wei-Chung Cheng, Ting-Ting Kuo, Juan-Cheng Yang, Yang-Chang Wu, Heng-Hsiung Wu, Chia-Chien Lo, Chih-Ying Hsieh, Sze-Ching Wong, Chih-Hao Lu, Wan-Ling Wu, Shih-Jen Liu, Yi-Chuan Li, Ching-Chan Lin, Chia-Ning Shen, Mien-Chie Hung, Jaw-Town Lin, Chun-Chieh Yeh, Yuh-Pyng Sher

ADAM9 drives the immunosuppressive microenvironment by cholesterol biosynthesis-mediated activation of IL6-STAT3 signaling for lung tumor progression

ADAM9通过胆固醇生物合成介导的IL6-STAT3信号通路激活,驱动免疫抑制性微环境,从而促进肺肿瘤进展。

Jing-Pei Liu ,Kuan-Yin Shen ,Wei-Chung Cheng ,Wei-Chao Chang ,Chih-Ying Hsieh ,Chia-Chien Lo ,Ting-Ting Kuo ,Ching-Chan Lin ,Shih-Jen Liu ,Wen-Chin Huang ,Yuh-Pyng Sher

Inhibition of CDCP1 by 8-isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment

8-异戊烯基柚皮素抑制 CDCP1 与 EGFR 抑制剂在肺癌治疗中产生协同作用

Sze-Ching Wong, Chun-Chieh Yeh, Xun-Yu Zhang, Chih-Ying Hsieh, Chia-Chien Lo, Ting-Ting Kuo, Ching-Chan Lin, Chih-Hua Chao, Jing-Pei Liu, Ling-Chu Chang, Lu-Hai Wang, Yuh-Pyng Sher

A disintegrin and metalloproteinase domain 9 facilitates SARS-CoV-2 entry into cells with low ACE2 expression

解整合素和金属蛋白酶结构域 9 促进 SARS-CoV-2 进入 ACE2 表达较低的细胞

Ivonne Melano, Wei-Chung Cheng, Li-Lan Kuo, Yuag-Meng Liu, Yu Chi Chou, Mien-Chie Hung, Michael M C Lai, Yuh-Pyng Sher, Wen-Chi Su

Using bioinformatics approaches to identify survival-related oncomiRs as potential targets of miRNA-based treatments for lung adenocarcinoma

使用生物信息学方法识别与生存相关的 oncomiR 作为基于 miRNA 的肺腺癌治疗的潜在靶点

Chia-Hsin Liu, Shu-Hsuan Liu, Yo-Liang Lai, Yi-Chun Cho, Fang-Hsin Chen, Li-Jie Lin, Pei-Hua Peng, Chia-Yang Li, Shu-Chi Wang, Ji-Lin Chen, Heng-Hsiung Wu, Min-Zu Wu, Yuh-Pyng Sher, Wei-Chung Cheng, Kai-Wen Hsu2

Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma

早期肺腺癌术后发生转移的诊疗因素识别

Wei-Chung Cheng, Chun-Yu Chang, Chia-Chien Lo, Chih-Ying Hsieh, Ting-Ting Kuo, Guan-Chin Tseng, Sze-Ching Wong, Shu-Fen Chiang, Kevin Chih-Yang Huang, Liang-Chuan Lai, Tzu-Pin Lu, K S Clifford Chao, Yuh-Pyng Sher

ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinoma

ADAM9 作为转录调节因子促进食管鳞状细胞癌的血管生成

Yu-Sen Lin, Ting-Ting Kuo, Chia-Chien Lo, Wei-Chung Cheng, Wei-Chao Chang, Guan-Chin Tseng, Shih-Ting Bai, Yu-Kai Huang, Chih-Ying Hsieh, Han-Shui Hsu, Yi-Fan Jiang, Chen-Yuan Lin, Liang-Chuan Lai, Xing-Guo Li, Yuh-Pyng Sher

Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma

系统鉴定临床相关 miRNA,为肺腺癌提供潜在的基于 miRNA 的治疗

Shu-Hsuan Liu, Kai-Wen Hsu, Yo-Liang Lai, Yu-Feng Lin, Fang-Hsin Chen, Pei-Hwa Peng, Li-Jie Lin, Heng-Hsiung Wu, Chia-Yang Li, Shu-Chi Wang, Min-Zu Wu, Yuh-Pyng Sher, Wei-Chung Cheng1

EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis

EFHD2 通过激活 NOX4-ROS-ABCC1 轴促进非小细胞肺癌顺铂耐药

Chi-Chen Fan, Sheng-Ta Tsai, Chen-Yuan Lin, Ling-Chu Chang, Juan-Cheng Yang, Guan-Yu Chen, Yuh-Pyng Sher, Shao-Chun Wang, Michael Hsiao, Wei-Chao Chang

Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells

Semaphorin 5A抑制肺腺癌细胞的增殖和迁移

Pin-Hao Ko, Govinda Lenka, Yu-An Chen, Eric Y Chuang, Mong-Hsun Tsai, Yuh-Pyng Sher, Liang-Chuan Lai